Back to top

LACOG 0421 – Action HIV

  /    /  LACOG 0421 – Action HIV

ACTION HIV (Anal Cancer TherapIes and Outcomes initiative for patients living with and without HIV): A global record of patients with anal squamous cell carcinoma with and without HIV infection.

Type of Study: Epidemiological

Sponsor / Support: LACOG and GTG – Grupo Brasileiro de Tumores Gastrointestinais

Primary Objectives: Describe the epidemiological characteristics and prognostic factors for disease-free survival of patients with CC with and without HIV infection.

Design: Epidemiological study of the retrospective, multicenter, multinational cohort, with data collection from medical records.

Sample Size: 300 patients

Principal Investigator: Rachel Riechelmann

Countries LATAM: Argentina, Brazil, Chile, Colombia, Dominican Republic and Mexico.

Clinicaltrials.gov Identifier: NCT05328765

The study is open to patients participation in the following research sites:

Brazil

A.C. Camargo Cancer Center / São Paulo / SP / Brazil

Hospital de Amor de Barretos / Barretos / SP / Brazil

Mexico

INCan - Instituto Nacional de Cancerología / Cidade do México / Mexico